Medfinder
Back to blog

Updated: January 4, 2026

Lynparza Shortage Update: What Patients Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Calendar with medication bottle showing drug availability update and trending graph

Is Lynparza in shortage in 2026? No—but access is still challenging. Here's the current status and what patients can do to get their medication.

Many patients prescribed Lynparza (olaparib) search for "Lynparza shortage" because they're experiencing real difficulty getting their medication. If that's you, here is the latest information on Lynparza's availability status—and what you can do about it.

Is Lynparza in Shortage in 2026?

No. As of 2026, Lynparza (olaparib) is not listed on the FDA Drug Shortages database. AstraZeneca has not issued any supply disruption notices for Lynparza. The drug is manufactured in sufficient quantities to meet current demand.

However—and this is important—the absence of an FDA-listed shortage does not mean patients are easily getting their medication. The barriers to Lynparza access are structural and systemic rather than supply-driven.

Why Do Patients Experience Access Problems If There's No Shortage?

Lynparza's access challenges stem from the way specialty drugs work in the U.S. healthcare system:

Specialty pharmacy requirement: Lynparza is only available through specialty pharmacies, not standard retail pharmacies.

Prior authorization delays: Most insurance plans—including Medicare Part D—require prior authorization before covering Lynparza. PA reviews can take days to weeks.

Biomarker testing delays: Lynparza requires FDA-approved companion diagnostic testing (BRCA/HRR gene testing) before it can be prescribed, which adds 1–4 weeks before even the prescription is written.

Cost barriers: Without insurance or assistance programs, Lynparza costs approximately $17,000–$20,000 per month. Patients without active coverage can't afford to pay out of pocket while a coverage dispute is resolved.

Has Lynparza Ever Been in Shortage?

Lynparza has not historically appeared on the FDA Drug Shortages database for supply-related reasons. One notable change in its history was the discontinuation of the original Lynparza capsule formulation from the U.S. market in August 2018, which was done voluntarily by AstraZeneca to reduce potential dosing confusion with the newer tablet formulation. This was not a shortage but a planned product transition.

Today, Lynparza is available only as 100 mg and 150 mg film-coated tablets. Supply of this formulation has remained consistent.

While Lynparza itself is not in shortage, some drugs used alongside it have experienced supply disruptions. Carboplatin and cisplatin—platinum-based chemotherapy agents frequently used before Lynparza is initiated—experienced significant nationwide shortages in 2023. These chemotherapy shortages affected the timing of Lynparza initiation for some patients, since many Lynparza maintenance indications require completion of platinum-based chemotherapy first.

As of 2026, platinum agent availability has largely stabilized, though patients should verify with their oncology team.

How to Monitor Lynparza Availability

FDA Drug Shortages Database (accessdata.fda.gov/scripts/drugshortages) — the official source for federally-tracked drug shortages

AstraZeneca's Access 360 program (1-844-275-2360) — can confirm current supply status and help with access issues

medfinder — calls pharmacies in your area to check which ones currently have Lynparza in stock

What to Do If You're Having Trouble Getting Lynparza

If you're struggling to fill your Lynparza prescription, here are your priority action steps:

Call your oncologist immediately to explain the access problem.

Contact AstraZeneca's Access 360 at 1-844-275-2360 for PA support, specialty pharmacy routing, and copay assistance enrollment.

Use medfinder to find pharmacies in your area that can fill Lynparza.

If cost is the barrier, apply for the AZ&Me Patient Assistance Program for free drug (for qualifying uninsured/underinsured patients).

Ask your oncologist about bridge supply options while insurance issues are resolved.

The Bottom Line for Patients

Lynparza is not in shortage in 2026. If you're having difficulty getting it, the problem is almost certainly an administrative one—insurance, prior authorization, or specialty pharmacy routing—that can be resolved. Don't wait or assume the situation is unfixable. See our guide on How to Find Lynparza In Stock Near You for step-by-step help.

Frequently Asked Questions

No. Lynparza (olaparib) is not on the FDA Drug Shortages database in 2026. AstraZeneca has not issued supply disruption notices. Access difficulties are driven by specialty pharmacy requirements, prior authorization delays, and cost barriers—not supply.

Lynparza has not historically been listed on the FDA Drug Shortage database for supply-related reasons. In 2018, AstraZeneca voluntarily discontinued the original capsule formulation (not tablets) to reduce dosing confusion—this was a planned product transition, not a shortage.

You can check the FDA Drug Shortages Database at accessdata.fda.gov/scripts/drugshortages for official shortage information. You can also contact AstraZeneca's Access 360 at 1-844-275-2360 or use medfinder to check which pharmacies near you currently have Lynparza in stock.

Most standard retail pharmacies do not carry Lynparza because it is a specialty medication. You need to use a designated specialty pharmacy. Your oncologist's office or AstraZeneca's Access 360 program can direct you to an appropriate specialty pharmacy that carries Lynparza.

Yes, indirectly. During the 2023 carboplatin shortage, some patients had delayed access to platinum-based chemotherapy, which is typically required before starting Lynparza maintenance therapy. As of 2026, platinum agent availability has largely stabilized, but patients should confirm with their oncology team.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Lynparza also looked for:

32,900 have already found their meds with Medfinder.

Start your search today.

32K+
5-star ratingTrusted by 32,900 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?